Note : Les revendications sont présentées dans la langue officielle dans laquelle elles ont été soumises.
THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A preparation for defoliating ox regulating the growth
of plants, which comprises a defoliating or growth-regulating
compound selected from 1,2,3-thiadiazol-5-yl-urea deriva-
tives and 1,2,3-thiadiazolin-2-ide derivatives, in admix-
ture or conjunction with an alkaline reacting substance,
the ratio by weight of the defoliating or growth-regulating
compound to the alkaline reacting substance being within the range
of from 1:0.5 to 1:1000.
2. A preparation as claimed in claim 1, wherein the de-
foliating or growth-regulating compound is a 1,2,3-thiadia-
zol-5-yl-urea derivative of the general formula I
<IMG> (I)
in which R1 represents a hydrogen atom or a C1-C5-alkyl group,
R2 represent a C1-C5-alkyl group, a C5-C8-cycloalkyl group,
a phenyl, halogenated phenyl, C1-C4-alkylphenyl, C1-C4-
alkoxyphenyl, nitrophenyl or trifluoromethylphenyl group, an
unsubstituted pyridyl or pyrimidyl group or a pyridyl or pyr-
imidyl group substituted by one or more substituents selected
from C1-C4-alkyl groups, C1-C4-alkoxy groups, halogen atoms,
nitro groups and trifluoromethyl groups, or R1 and R2 together
with the adjacent nitrogen atom represents a morpholino,
piperidino or pyrrolidino group, R3 represents a hydrogen
atom or a C1-C5-alkyl group, and X represents an oxygen or
sulphur atom.
3. A preparation as claimed in claim 2, wherein the 1,2,3-
thiadiazol-5-yl-urea derivative is selected from the group
consisting of 1-Phenyl-3-(1,2,3-thiadiazol-5-yl)-urea
1-Phenyl-1-methyl-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Chlorophenyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-Cyclohexyl-3-(1,2,3-thiadiazol-5-yl)-urea
1-(3-Chlorophenyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Methylphenyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(3-Methylphenyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(3,4-Dichlorophenyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-Methyl-3-(1,2,3-thiadiazol-5-yl)-urea
1,1-Dimethyl-3-(1,2,3-thiadiazol-5-yl)-urea
1,1-Dimethyl-3-methyl-3-(1,2,3-thiadiazol-5-yl)-urea
1-Methyl-3-methyl-3-(1,2,3-thiadiazol-5-yl)-urea
1-Phenyl-3-(1,2,3-thiadiazol-5-yl)-thiourea
1-(4-Chlorophenyl)-3-(1,2,3-thiadiazol-5-yl)-thiourea
1-(2-Pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(5-Chloro-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Methyl-2-pyrimidyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(3-Pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(2-Pyrimidyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(3-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(5-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea and
1-(6-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea.
4. A preparation as claimed in claim 2, wherein the 1,2,3-
thiadiazol-5-yl-urea derivative is 1-phenyl-3-(1,2,3-thia-
diazol-5-yl)-urea.
5. A preparation as claimed in claim 2, wherein the 1,2,3-
thiadiazol-5-yl-urea derivative is 1-phenyl-1-methyl-3-
(1,2,3-thiadiazol-5-yl)-urea.
6. A preparation as claimed in claim 2, wherein the 1,2,3-
thiadiazol-5-yl-urea derivative is 1-(2-pyridyl)-3-(1,2,3-
thiadiazol-5-yl)-urea.
7. A preparation as claimed in claim 1, wherein the de-
foliating or growth-regulating compound is a 1,2,3-thiadia-
zolin-2-ide derivative of the general formula II
26
<IMG>
(II)
in which R1 represents a hydrogen atom or a C1-C5-alkyl group,
R2 represents a hydrogen atom, a C1-C5-alkyl group, a C5-C8-
cycloalkyl group, a phenyl, halogenated phenyl, C1-C4-alkyl-
phenyl, C1-C4-alkoxyphenyl, nitrophenyl or trifluoromethyl-
phenyl group, an unsubstituted pyridyl or pyrimidyl group or
a pyridiyl or pyrimidyl group substituted by one or more sub-
stituents selected from C1-C4-alkyl groups, C1-C4-alkoxy
groups, halogen atoms, nitro groups and trifluoromethyl
groups, or R1 and R2 together with the adjacent nitrogen
atom represent a morpholino, piperidino or pyrrolidino
group, B represents an alkali metal atom or a monovalent
equivalent of zinc, manganese, calcium, magnesium or barium,
and X represents an oxygen or sulphur atom.
8. A preparation as claimed in claim 7, wherein B repre-
sents a lithium, sodium or potassium atom.
9. A preparation as claimed in claim 7, wherein the 1,2,3-
thiadiazolin-2-ide derivative is selected from the group
consisting of:
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, sodium
salt xH2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, calcium
salt x8H2O
5-(Phenylcarbamoyliminol)-1,2,3-thiadiazolin-2-ide, potassium
salt xH2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, lithium
salt x4H2O
5-(Methylphenylcarbamoyliminol-1,2,3-thiadiazolin-2-ide,
sodium salt xH2O
5-(Methylphenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
potassium salt xH2O
27
5-(Methylphenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
lithium salk xH2O
5-(2 Pyridylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
sodium salt x1.5 H2O
5-(2-Pyridylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
potassium salt xH20
5-(2-Pyridylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
lithium salt xH2O
5-(Phenylthiocarbamoylimino)-1,2,3-thiadiazolin-2-ide,
sodium salt xH2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, magnesium
salt x2H2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, zinc salt
x3H2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, manganese
salt x3H20
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, barium
salt x3H20.
10. A preparation as claimed in claim 7, wherein the 1,2,3-
thiadiazolin-2-ide derivative is the calcium salt of 5-
(phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide.
11. A preparation as claimed in claim 7, wherein the 1,2,3-
thiadiazolin-2-ide derivative is the magnesium salt of 5-
(phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide.
12. A preparation as claimed in claim 7, wherein the 1,2,3-
thiadiazolin-2-ide derivative is the manganese salt of 5-
(phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide.
13. A preparation as claimed in claim 13, wherein the
alkaline reacting substance is an alkali hydroxide, an amine,
a carbonate, a phosphate or an alkali salt of a monocarboxylic
acid.
14. A preparation as claimed in claim 13, wherein the alkali
hydroxide is sodium or potassium hydroxide.
15. A preparation as claimed in claim 13, wherein the amine
28
is triethylamine, diethanolamine, triethanolamine, triiso-
propanolamine or hexamethylenetetramine.
16. A preparation as claimed in claim 13, wherein the car-
bonate is sodium carbonate, potassium carbonate or ammonium
carbonate.
17. A preparation as claimed in claim 13, wherein the phos-
phate is trisodium phosphate, tripotassium phosphate, tetra-
sodium pyrophosphate or tetrapotassium pyrophosphate.
18. A preparation as claimed in claim 13, wherein the alkali
salt of a monocarboxylic acid is sodium oleate.
19. A preparation as claimed in claim 1, which comprises
1-phenyl-3-(1,2,3-thiadiazol-5-yl)-urea as the defoliating
or growth-regulating compound in admixture with potassium
hydroxide, potassium carbonate, ammonium carbonate, tetra-
potassium pyrophosphate, triethylamine, triethanolamine or
sodium oleate. as the alkaline reacting substance.
20. A preparation as claimed in claim 1, which comprises
1-(2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea as the defol-
iating or growth-regulating compound in admixture with pot
assium carbonate as the alkaline reacting substance.
21. A preparation as claimed in claim 1, which comprises
the calcium salt of 5-(phenylcarbamoylimino)-1,2,3-thiadia-
zolin-2-ide as the defoliating or growth-regulating compound
in admixture with potassium carbonate as the alkaline reacting
substance
22. A preaparation as claimed in claim 1 having a pH-value
greater than 8.
23. A preparation as claimed in claim 22, having a pH-value
within the range of from 9.5 to 11.5.
24. A preparation as claimed in claim 1, which also contains
at least one of a liquid carrier and a solid carrier.
29
25. A preparation as claimed in claim 24, containing 5 to
95% by weight of the defoliating or growth-regulating
compound and the alkaline reacting substance and 95 to 5%
by weight of at least one of the liquid and solid carriers.
26. A preparation as claimed in claim 1, which also contains
a surface-active agent.
27. A preparation as claimed in claim 26, containing the
surface-active agent in an amount of up to 30% by weight.
28. A preparation as claimed in claim 1, 2 or 3, which also
contains one or more active substances selected from defol-
iating agents, plant-protecting agents and pesticides other
than 1,2,3-thiadiazol-5-yl-urea derivatives and 1,2,3-
thiadiazolin-2-ide derivatives.
29. A preparation as claimed in claim 1,2 or 3, which is in
the form of a powder, a strewable preparation, a solution,
an emulsion or a suspension.
30. A preparation selected from the group comprising of:
a) 95% by weight of mixture
4% by weight of kaolin
1% by weight of surface-active agents based on the
sodium salt of N-methyl-N-oleyl-taurine
and the calcium salt of lignin sulphon-
ic acid
b) 80% by weight of mixture
10% by weight of calcium salt of lignin sulphonic acid
3% by weight of ammonium salt of the monosulphuric
acid ester of tetraethylene glycol
nonyl phenyl ether
7% by weight of colloidal silicic acid
c) 20% by weight of mixture
70% by weight of tonsil
8% by weight of cellulose pitch
2% by weight of wetting agent based on a fatty acid
condensation product
and
d) 5% by weight of mixture
80% by weight of tonsil
10% by weight of cellulose pitch
5% by weight of wetting agent based on a fatty acid
condensation product,
31
said mixture being the mixture of a defoliating or growth-
regulating compound selected from 1,2,3-thiadiazol-5-vl-urea
derivatives and 1,2,3-thiadiazolin-2-ide derivatives, with an alkaline
reacting substance, the ratio by weight of the defoliating or growth-
regulating compound to the alkaline reacting substance being within
the range of from 1:0.5 to 1:1000.
31. A method of defoliating or regulating the
growth of a living plant at the stage of having at least 5
foliage leaves, wherein the living plant is treated with a
mixture comprising (i) a defoliating or growth regulating
compound selected from 1,2,3-thiadiazol-5-yl-urea derivatives
and 1,2,3-thiadiazolin-2-ide derivatives and (ii) an alkaline
reacting substance, the ratio by weight of the defoliating or
growth-regulating compound to the alkaline reacting substance
by within the range of from 1:0.5 to 1:1000.
32. A method as claimed in claim 31, wherein the
defoliating or growth-regulating compound is a 1,2,3-thiadia-
zol-5-yl-urea derivative of the general formula I given in
claim 2, in which R1, R2, R3 and X have the meanings given
in claim 2.
33. A method as claimed in claim 32, wherein the
1,2,3-thiadiazol-5-yl-urea derivative is selected from the
group consisting of: 1-phenyl-3-(1,2,3-thiadiazol-5-yl)-
urea; 1-phenyl-1-methyl-3-(1,2,3-thiadiazol-5-yl)-urea;
1-(4-chlorophenyl)-3-(1,2,3-thiadiazol-5-yl)-urea; 1-cyclo-
hexyl-3-(1,2,3-thiadiazol-5-yl)-urea; 1-(3-chlorophenyl)-3-
(1,2,3-thiadiazol-5-yl)-urea; 1-(4-methylphenyl)-3-(1,2,3-
thiadiazol-5-yl)-urea; 1-(3-methylphenyl)-3-(1,2,3-thiadiazol-
5-yl)-urea; 1-(3,4-dichlorophenyl)-3-(1,2,3-thiadiazol-5-
yl)-urea; 1-methyl-3-(1,2,3-thiadiazol-5-yl)-urea; 1,1-
dimethyl-3-(1, 2, 3-thiadiazol-5-yl)-urea; 1,1-dimethyl-3-methyl-
(1,2,3-thiadiazol-5-yl)-urea; 1-methyl-3-methyl-3-(1,2,3-thia-
32
diazol-5-yl)-urea; 1-phenyl-3-(1,2,3-thiadiazol-5-yl)-thiourea;
1-(4-chlorophenyl)-3-(1,2,3-thiadiazol-5-yl)-thiourea;
1-(2-Pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(5-Chloro-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Methyl-2-pyrimidyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(3-Pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(2-Pyrimidyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(3-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(5-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea and
1-(6-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea.
34. A method as claimed in claim 32, wherein the 1,2,3-
thiadiazol-5-yl-urea derivative is 1-phenyl-3-(1,2,3-thia-
diazol-5-yl)-urea.
35. A method as claimed in claim 32, wherein the 1,2,3-
thiadiazol-5-yl-urea derivative is 1-phenyl-1-methyl-3-
(1,2,3-thiadiazol-5-yl)-urea.
36. A method as claimed in claim 32, wherein the 1,2,3-
thiadiazol-5-yl-urea derivative is 1-(2-pyridyl)-3-(1,2,3-
thiadiazol-5-yl)-urea.
37. A method as claimed in claim 32, wherein the defoliating
or growth-regulating compound is a 1,2,3-thiadiazolin-2-ide
derivative of the general formula II given in claim 7, in
which R1, R2, B and X have the meanings given in claim 7.
38. A method as claimed in clalm 37, wherein B represents
a lithium, sodium or potassium atom.
39. A method as claimed in claim 37, wherein the 1,2,3-
thiadiazolin-2-ide derivative is selected for the group
consisting of:
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, sodium
salt xH2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, calcium
salt x8H2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, potassium
salt xH2O
34
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, lithium
salt x4H2O
5-(Methylphenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
sodium salt xH20
5-(Methylphenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
potassium salt xH2O
5-(Methylphenylcarbamoylmino)-1,2,3-thiadiazolin-2-ide,
lithium salt xH2O
5-(2-Pyridylcarbamoylimino )-1,2,3-thiadiazolin-2-ide,
sodium salt x1.5 H2O
5-(2-Pyridylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
potassium salt xH2O
5-(2-Pyridylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
lithium salt xH2O
5-(Phenylthiocarbamoylimino)-1,2,3-thiadiazolin-2-ide,
sodium salt xH2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, magnesium
salt x2H2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, zinc salt
x3H2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, manganese
salt x3H2O and
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, barium
salt x3H2O.
40. A method as claimed in claim 37, wherein the 1,2,3-
thiadiazolin-2-ide, derivative is the calcium salt of 5-
(phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide.
41. A method as claimed in claim 37, wherein the 1,2,3-
thiadiazolin-2-ide derivative is the magnesium salt of 5-
(phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide.
42. A method as claimed in cl.aim 37, wherein the 1,2,3-
thiadiazolin-2-ide derivative is the manganese salt of 5-
(phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide.
43. A method as claimed in claim 31, wherein the alkaline
reacting substance is an alkali hydroxide, an amine, a
carbonate, a phosphate or an alkali salt of a monocarboxylic
acid.
44. A method as claimed in claim 43, wherein the alkali
hydroxide is sodium or potassium hydroxide
45. A method as claimed in cliam 43, wherein the amine
is triethylamine, diethanolamine, triethanolamine, triiso-
propanolamine or hexamethylenetetramine.
46. A method as claimed in claim 43, wherein the carbonate
is sodium carbonate, potassium carbonate or ammonium carbon-
ate.
47. A method as claimed in claim 43, wherein the phosphate
is trisodium phosphate, tripotassium phosphate, tetrasodium
pyrophosphate or tetrapotassium pyrophosphate.
48. A method as claimed in claim 43, wherein the alkali
salt of a monocarboxylic acid is sodium oleate.
49. A method as claimed in claim 31, wherein the mixture
is a mixture comprising 1-phenyl-3-(1,2,3-thiadiazol-5-yl)-
urea and potassium hydroxide, potassium carbonate, ammonium
carbonate, tetrapotassium pyrophosphate, triethylamine,
triethanolamine or sodium oleate.
50. A method as claimed in claim 31, wherein the mixture is
a mixture comprising 1-(2-pyridyl)-3-(1,2,3-thiadiazol-5-
yl)-urea and potassium carbonate.
51. A method as claimed in claim 31, wherein the mixture
is a mixture comprising the calcium salt of 5-(phenylcarba-
moylimino)-1,2,3-thiadiazolin-2-ide and potassium carbonate.
52. A method as claimed in claim 31, wherein the pH-value
of the mixture is greater then 8.
53. A method as claimed in claim 52, wherein the pH-value
of the mixture is within the range of from 9.5 to 11.5.
54. A method as claimed in claim 31, wherein the mixture
also contains at least one of a liquid carrier and a solid
carrier.
36
55. A method as claimed in claim 54, wherein the mixture
contains 5 to 95% by weight of the defoliating or growth-
regulating compound and the alkaline reacting substance
and 95 to 5% being of at least one of the liquid and solid
carriers.
56. A method as claimed in claim 31, wherein the mixture
also contains a surface-active agent.
57. A method as claimed in claim 56, wherein the mixture
contains up to 30% by weight of the surface-active agent.
58. A method as claimed in claim 31, 32, or 33, wherein the
mixture also contains one or more active substances selected
from defoliating agents, plant-protecting agents and pestici-
des other than 1,2,3-thiadiazol-5-yl-urea derivatives and
1,2,3-thiadiazolin-2-ide derivatives.
59. A method as claimed in claim 31, 32 or 33, wherein the
mixture is in the form of a powder, a strewable preparation,
a solution, an emulsion or a suspension.
60. A method as claimed in claim 31, wherein the mixture
is selected from the group consisting of:
a) 95% by weight of mixture
4% by weight of kaolin
1% by weight of surface-active agents based on the
sodium salt of N-methyl-N-oleyl-taurine
and the calcium salt of lignin sulphon-
ic acid
b) 80% by weight ofmixture
10% by weight of calcium salt of lignin sulphonic acid
3% by weight of ammonium salt of the monosulphuric
acid ester of tetraethylene glycol
nonyl phenyl ether
7% by weight of colloidal silicic acid
c) 20% by weight of mixture
70% by weight of tonsil
8% by weight of cellulose pitch
2% by weight of wetting agent based on a fatty acid
37
condensaton product
and
d) 5% by weight of mixture
80% by weight of tonsil
10% by weight of cellulose pitch
5% by weight of wetting agent based on a fatty acid
condensation product
38
said mixture being the mixture of a defoliating or growth-
regulating compound selected from 1,2,3-thiadiazol-5-yl-urea
derivatives and 1,2,3-thiadiazolin-2-ide derivatives, with
an alkaline reacting substance, the ratio by weight of the
defoliating or growth-regulating compound to the alkaline
reacting substance being within the range of from 1:0.5 to
1:1000.
61. A method of defoliating or regulating the growth
of plants, at the stage of having at least 5 foliage leaves
in a crop area, wherein the crop area is treated with a mixture
comprising (i) a defoliating or growth-regulating compound
selected from 1,2,3-thiadiazol-5-yl-urea derivatives and 1,2,3-
thiadiazolin-2-ide derivatives and (ii) an alkaline reacting
substance, the ratio by weight of the defoliating growth-
regulating compound to the alkaline reacting substance being
within the range of from 1:0.5 to 1:1000.
62. A method as claimed in claim 61, wherein the
defoliating or growth-regulating compound is a 1,2,3-thia-
diazol-5-yl-urea derivative of the general formula I given
in claim 2, in which R1, R2, R3 and X have the meanings given
in claim 2.
63. A method as claimed in claim 62, wherein the
1,2,3-thiadiazol-5-yl-urea derivative is selected from the
group consisting of: 1-phenyl-3-(1,2,3-thiadiazol-5-yl)-urea;
1-phenyl-1-methyl-3-(1,2,3-thiadiazol-5-yl)-urea; 1-(4-chloro-
phenyl)-3-(1,2,3-thiadiazol-5-yl)-urea; 1-cyclohexyl-3-(1,2,3-
thiadiazol-5-yl)-urea; 1-(3-chlorophenyl)-3-(1,2,3-thiadiazol-
5-yl)-urea; 1-(4-methylphenyl)-3-(1,2,3-thiadiazol-5-yl)-urea;
1-(3-methylphenyl)-3-(1,2,3-thiadiazol-5-yl)-urea; 1-(3,4-
dichlorophenyl)-3-(1,2,3-thiadiazol-5-yl)-urea; 1-methyl-3-
(1,2,3-thiadiazol-5-yl)-urea; 1,1-dimethyl-3-(1,2,3-thiadiazol-
5-yl)-urea; 1,1-dimethyl-3-methyl-3-(1,2,3-thiadiazol-5-yl)-
urea; 1-methyl-3-methyl-3-(1,2,3-thiadiazol-5-yl)-urea; 1-
phenyl-3-(1,2,3-thiadiazol-5-yl)-thiourea;
39
1-(4-Chlorophenyl)-3-(1,2,3 thiadiazil-5-yl)-thiourea
1-(2-Pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(5-Chloro-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Methyl-2-pyrimidyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(3-Pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(2-Pyrimidyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(3-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(5-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea and
1-(6-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea.
64. A method as claimed in claim 62, wherein the 1,2,3-thiadiazol-
5-yl-urea derivative is 1-phenyl-3-(1,2,3-thiadiazol-5-yl)-urea.
65. A method as claimed in claim 62, wherein the 1,2,3-thiadiazol-
5-yl-urea derivative is 1-phenyl-1-methyl-3-(1,2,3-thiadiazol-5-yl)-
urea.
66. A method as claimed in claim 62, wherein the 1,2,3-thiadiazol-5-
yl-urea derivative is 1-(2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea.
67. A method as claimed in claim 61, wherein the defoliating or grow-
th-regulating ccmpound is a 1,2,3-thiadiazolin-2-ide derivative of the
general formula II given in claim 7, in which R1, R2, B and X have the
meanings given in claim 7.
68. A method as claimed in claim 67, wherein B represents a lithium,
sodium or potassium atom.
69. A method as claimed in claim 67, wherein the 1,2,3-thiadiazolin-
2-ide derivative selected from the group consisting of:
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, sodium salt xH2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, calcium salt x8H2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, potassium salt xH2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, lithium salt x4H2O
5-(Methylphenylcarbamoylimino)-1,2,3-thiadaizolin-2-ide,
sodium salt xH2O
5-(Methylphenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
potassium salt xH2O
5-(Methylphenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
lithium salt xH2O
5-(2-Pyridylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
sodium salt x1.5 H2O
5-(2-Pyridylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
potassium salt xH2O
5-(2-Pyridylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
lithium salt xH2O
5-(Phenylthiocarbamoylimino)-1,2,3-thiadiazolin-2-ide,
sodium salt xH2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, magnesium
salt x2H2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, zinc
salt x3H2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, manganese
salt x3H2O and
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, barium
salt x3H2O.
70. A method as claimed in claim 67, wherein the 1,2,3-
thiadiazolin-2-ide derivative is the calcium salt of 5-
(phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide.
71. A method as claimed in claim 67, wherein the 1,2,3-
thiadiazolin-2-ide derivative is the magnesium salt of 5-
(phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide.
72. A method as claimed in claim 67, wherein the 1,2,3-
thiadiazolin-2-ide derivative is the manganese salt of 5-
(phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide.
73. A method as claimed in claim 61, wherein the alkaline
reacting substance is an alkali hydroxide, an amine, a car
bonate, a phosphate or an alkali salt of a monocarboxylic
acid.
41
74. A method as claimed in claim 73, wherein the alkali
hydroxide is sodium or potassium hydroxide.
75. A method as claimed in claim 73, wherein the amine
is triethylamine, diethanolamine, triethanolamine, triiso-
propanolamine or hexamethylenetetramine.
76. A method as claimed in claim 73, wherein the carbonate
is sodium carbonate, potassium carbonate or ammonium car-
bonate.
77. A method as claimed in claim 73, wherein the phosphate
is trisodium phosphate, tripotassium phosphate, tetrasodium
pyrophosphate or tetrapotassium pyrophosphate.
78. A method as claimed in claim 73, wherein the alkali
salt of a monocarboxylic acid is sodium oleate.
79. A method as claimed in claim 61, wherein the mixture is
a mixture comprising 1-phenyl-3-(1,2,3-thiadiazol-5-yl)-
urea and potassium hydroxide, potassium carbonate, ammonium
carbonate, tetrapotassium pyrophosphate, triethylamine, tri-
ethanolamine or sodium oleate.
80. A method as claimed in claim 61, wherein the mixture is
a mixture comprising 1-(2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-
urea and potassium carbonate.
81. A method as claimed in claim 61, wherein the mixture
is a mixture comprising the calcium salt of 5-(phenylcarba-
moylimino)-1,2,3-thiadiazolin-2-ide and potassium carbonate.
82. A method as claimed in claim 61, wherein the pH-value of
the mixture is greater than 8.
83. A method as claimed in claim 82, wherein the pH-value
of the mixture is within the range of from 9.5 to 11.5.
84. A method as claimed in claim 61, wherein the mixture
also contains at least one of a liquid carrier and a solid
carrier.
85. A method as claimed in claim 84, wherein the mixture
contains 5 to 95% by weight of the defoliating or growth-
42
regulating compound and the alkaline reacting substance and
95 to 5% by weight of at least one of the liquid and solid
carriers.
86. A method as claimed in claim 61, wherein the mixture
also contains a surface-active agent.
87. A method as claimed in claim 86, wherein the mixture
contains up to 30% by weight of the surface-active agent.
88. A method as claimed in claim 61, 62, or 63, wherein the
mixture also contains one or more active substances selected
from defoliating agents, plant-protecting agents and pestici-
des other than 1,2,3-thiadiazol-5-yl-urea derivatives and
1,2,3-thiadiazolin-2-ide derivatives.
89. A method as claimed in claim 61, 62, or 63, wherein the
mixture is in the form of a powder, a strewable preparation,
a solution, an emulsion or a suspension.
90. A method as claimed in claim 61, wherein the mixture is
selected from the group consisting of:
a) 95% by weight of mixture
4% by weight of kaolin
1% by weight of surface-active agents based on the
sodium salt of N-methyl-N-oleyl-taurine
and the calcium salt of lignin sulphon-
ic acid
b) 80% by weight of mixture
10% by weight of calcium salt of lignin sulphonic acid
3% by weight of ammonium salt of the monosulphuric
acid ester of tetraethylene glycol
nonyl phenyl ether
7% by weight of colloidal silicic acid
c) 20% by weight of mixture
70% by weight of tonsil
8% by weight of cellulose pitch
2% by weight of wetting agent based on a fatty acid
condensation product
43
and
d) 5% by weight of mixture
80% by weight of tonsil
10% by weight of cellulose pitch
5% by weight of wetting agent based on a fatty acid
condensation product
said mixture being the mixture of a defoliating or growth-
regulating compound selected from 1,2,3-thiadiazol-5-yl-
urea derivatives and 1,2,3-thiadiazolin-2-ide derivatives,
with an alkaline reacting substance, the ratio by weight of
the defoliating or growth-regulating compound to the alkaline
reacting substance being within the range of from 1:0.5 to
1:1000.
91. A method as claimed in claim 61, wherein the
total amount of the defoliating or growth-regulating compound
and the alkaline reacting substance used for the treatment
is within the range of from 1 to 10,000 grams per hectare.
92. A method as claimed in claim 91, wherein the
total amount is within the range of from 10 to 1000 grams per
hectare.
93. A method as claimed in any one of claims 81,
82 or 83, wherein the crop area contains cotton plants.
44